DAKAR, 21 August 2014 (IRIN) - Ebola’s devastation in West Africa has catapulted experimental drugs from labs to patients and shaken up vaccine development, which was hitherto patchy as outbreaks of the virus have tended to be spasmodic and geographically limited.

“There is no market for Ebola vaccines,” Marie-Paule Kieny, World Health Organization (WHO) assistant director-general, told IRIN. “Outside of an outbreak, who would want to get vaccinated against Ebola? Nobody. Therefore the market...


This story is part of New Europe's Premium content.

To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑
new europe join now